Searched for
CRAMS BUSINESS
‘Studied just 2-3 hours': CBSE class 12 topper AIR 1 reveals smart revision strategy & last-minute preparation that helped him secure top rankAhmedabad student Krishiv Achyut Dani has secured All India Rank 1 (AIR 1) in the CBSE Class 12 examinations. He credits his success to a d...- Italian proverb of the day: 'He who goes slowly goes safely and goes far.' Life lessons on patience, slow growth and why slow progress beats fast successAn ancient Italian proverb, "Chi va piano va sano e va lontano," meaning "He who goes slowly goes safely and goes far," offers a vital coun...
- lndiaRF to acquire API, CRAMS business of Ind-Swift LabsIndiaRF will acquire the active pharmaceutical ingredients (API) and contract research and manufacturing services (CRAMS) business of Ind-S...
- Aether Industries inks pact with Saudi Aramco TechnologiesSaudi Aramco Technologies and Aether had previously developed and validated this manufacturing process on a pre-commercial scale, Aether In...
- Advent pips Blackstone, set to buy Suven Pharma for Rs 6300 crMarket capitalisation of Suven Pharma, as on Friday, was ₹12,682.43 crore. ET was the first to report on the sale on December 23. Advent is...
- Buy Suven Pharma, target price Rs 690: ICICI DirectThe brokerage says despite a significant run up, there is still scope for upside as the company is still trading at a significant discount ...
- Suven Life Sciences to set up subsidiary in US, to infuse $75 millionThe board of directors has approved investment of USD 75 million in the said WOS for new business opportunities and acquisitions,the compan...
- Aurobindo Pharma eyes 25% revenue from custom research businessAurobindo Pharma is eyeing to garner at least 25% of its annual revenues from the custom research and manufacturing (Crams) business in the...
- Global consolidation hits Indian contract drug manufacturing cosMany global research firms, such as Pfizer, GSK and Merck, have announced massive cost-cutting measures, including expenses in R&D.
- Drug formulations pep up sector, but contract research spoils Q3 partyHowever, pharma companies mainly into formulations have managed to show strong growth, except for those who had operations in Germany and s...
- Contract jobs to keep pharma cos healthyBut the slowdown and the liquidity crisis have taken the sheen off auto components, with the focus now shifting to another segment: contrac...
- Citigroup Global Markets retains 'buy' on Piramal HealthcareCitigroup Global Markets has retained its ‘buy’ rating on Piramal Healthcare, citing strong growth prospects and attractive valuations as t...
- Pharma R&D offshoring wards off slowdownContract Research & Manufacturing (CRAM) business of pharma companies has picked up pace amidst global economic crisis.
- High input costs, falling rupee make pharma firms trim Crams bizIndian pharma companies, which till a year back had identified $1 billion of business opportunities in Contract Research and Manufacturing ...
- Plethico Pharma looks at trimming its CRAMS businessPlethico Pharmaceuticals said it is looking at trimming its Contract Research and Manufacturing Services business.
- Jubilant hunts for buys abroadJubilant Organosys is evaluating various proposals to acquire companies in the contract research and manufacturing services (CRAMS), drug d...
- Lupin buys Baroda co RubaminRLL, a subsidiary of the Rubamin group, manufactures advanced intermediates and Active Pharmaceutical Ingredients (APIs) and provides resea...
- Wockhardt plans CRAM play to bag big US, European dealsDomestic pharma major Wockhardt has decided to enter the lucrative contract manufacturing (CRAM) space from the next fiscal.
- Shasun to project R&D identityChennai-based Shasun Chemicals and Drugs is aiming to change its image as a bulk drug manufacturer to one of a research-driven company in t...
- Shasun to project R&D identityThe Chennai-based Shasun Chemicals and Drugs is aiming to change its image as a bulk drug manufacturer to one of a research-driven company ...
Load More
